Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Furuya

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Cancers|August 26, 2022
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150Takuya Sho, Goki Suda, Yoshiya Yamamoto, et al.
Journal of Gastroenterology|February 20, 2019
Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infectionGoki Suda, Chitomi Hasebe, Masami Abe, et al.
Scientific Reports|January 17, 2020
Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitisKoji Ogawa, Takashi Kobayashi, Jun-Ichi Furukawa, et al.
Liver Cancer|June 16, 2023
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab TreatmentShunichi Hosoda, Goki Suda, Takuya Sho, et al.
The American Journal of Gastroenterology|October 26, 2016
Accuracy of CT Colonography for Detection of Polypoid and Nonpolypoid Neoplasia by Gastroenterologists and Radiologists: A Nationwide Multicenter Study in JapanKoichi Nagata, Shungo Endo, Tetsuro Honda, et al.
Journal of Medical Virology|January 4, 2023
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitisGoki Suda, Masaru Baba, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 4, 2024
Distribution of Fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction-associated steatotic liver disease in health check-upYuji Ogawa, Wataru Tomeno, Yasushi Imamura, et al.
Journal of Gastroenterology|July 19, 2018
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infectionGoki Suda, Masayuki Kurosaki, Jun Itakura, et al.
Journal of Gastroenterology|June 1, 2017
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in JapanGoki Suda, Norihiro Furusyo, Hidenori Toyoda, et al.
Pancreas|June 1, 2018
Management of Pancreatolithiasis: A Nationwide Survey in JapanKazuo Inui, Atsushi Masamune, Yoshinori Igarashi, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Cancers|August 26, 2022
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150Takuya Sho, Goki Suda, Yoshiya Yamamoto, et al.
Journal of Gastroenterology|February 20, 2019
Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infectionGoki Suda, Chitomi Hasebe, Masami Abe, et al.
Scientific Reports|January 17, 2020
Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitisKoji Ogawa, Takashi Kobayashi, Jun-Ichi Furukawa, et al.
Liver Cancer|June 16, 2023
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab TreatmentShunichi Hosoda, Goki Suda, Takuya Sho, et al.
The American Journal of Gastroenterology|October 26, 2016
Accuracy of CT Colonography for Detection of Polypoid and Nonpolypoid Neoplasia by Gastroenterologists and Radiologists: A Nationwide Multicenter Study in JapanKoichi Nagata, Shungo Endo, Tetsuro Honda, et al.
Journal of Medical Virology|January 4, 2023
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitisGoki Suda, Masaru Baba, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 4, 2024
Distribution of Fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction-associated steatotic liver disease in health check-upYuji Ogawa, Wataru Tomeno, Yasushi Imamura, et al.
Journal of Gastroenterology|July 19, 2018
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infectionGoki Suda, Masayuki Kurosaki, Jun Itakura, et al.
Journal of Gastroenterology|June 1, 2017
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in JapanGoki Suda, Norihiro Furusyo, Hidenori Toyoda, et al.
Pancreas|June 1, 2018
Management of Pancreatolithiasis: A Nationwide Survey in JapanKazuo Inui, Atsushi Masamune, Yoshinori Igarashi, et al.
Pageof 7